| Authors: |
Knoll N; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia.; University of Heidelberg, Heidelberg, Germany., Masser S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz and BioTechMed-Graz, Graz, Austria., Bordas B; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia., Ebright RY; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Li G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Kesar D; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Destefanis E; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia., Kania N; Dana-Farber Cancer Institute, Boston, Massachusetts., Rodriguez DJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Jen J; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Zagar SE; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia., Mensah C; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia., Chen Z; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts., Moffitt SJ; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia., Enakireru EM; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Erasmus Mundus Joint Masters. University of Calabria, Calabria, Italy., He Y; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Feng B; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Chokshi MK; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Jin CY; Dana-Farber Cancer Institute, Boston, Massachusetts., Raghavan S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Sellers WR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Mulvaney KM; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia. |
